Multicenter Prospective Registry to Evaluate Use and Outcomes of NanoBoneae Bone Graft Substitute in Acute Trauma Patients

What this Trial Is About

Researchers are documenting how orthopedic surgeons use NanoBoneae Bone Graft products in treating acute fractures caused by blunt or penetrating trauma, focusing on patient outcomes. This patient registry study tracks fracture healing through X-rays and assesses improvements in symptoms and function based on reports from both investigators and patients. The study also records any product-related adverse events to better understand the outcomes of using NanoBone in acute trauma cases. The study observes the use of NanoBoneae Bone Graft applied during surgery as either a stand-alone bone graft or combined with local bone, without other bone graft substitutes or biologic products. Surgeons independently decide the surgical technique and specific NanoBone product to use. This observational registry captures data at multiple time points including 2 weeks, 6 weeks, 3 months, and 6 months after treatment. Participants will undergo assessments including radiographic imaging to evaluate fracture healing and clinical evaluations of pain relief at scheduled intervals up to 6 months. Patient-reported outcome measures will also be collected to track symptom and function improvements. The study involves ongoing monitoring of treatment results and adherence to post-operative care plans to gather comprehensive data on the use and effectiveness of NanoBoneae Bone Graft in acute trauma patients.

Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma